(Q39411371)

English

Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation.

scientific article published on 18 January 2012

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

based on heuristic

inferred from title

atypical teratoid rhabdoid tumor

1 reference

based on heuristic

inferred from title

Ramon Lopez Perez

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

C Blattmann

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

S Oertel

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

M Thiemann

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

K J Weber

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

P Schmezer

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

O Zelezny

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

A E Kulozik

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

J Debus

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

V Ehemann

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

18 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Strahlentherapie und Onkologie

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

188

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

168-176

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Vorinostat enhances the radiosensitivity of a breast cancer brain metastatic cell line grown in vitro and as intracranial xenografts

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Chemical agents that promote chromatin compaction radiosensitize tumour cells

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Enhancement of radiation response in osteosarcoma and rhabdomyosarcoma cell lines by histone deacetylase inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Enhanced radiation-induced cell killing and prolongation of gammaH2AX foci expression by the histone deacetylase inhibitor MS-275.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Low-dose valproic acid enhances radiosensitivity of prostate cancer through acetylated p53-dependent modulation of mitochondrial membrane potential and apoptosis

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Modulation of radiation response by histone deacetylase inhibition

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Epigenetic therapy using the histone deacetylase inhibitor for increasing therapeutic gain in oral cancer: prevention of radiation-induced oral mucositis and inhibition of chemical-induced oral carcinogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Cytometric assessment of histone H2AX phosphorylation: a reporter of DNA damage

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

The epigenetic modifier, valproic acid, enhances radiation sensitivity

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

DNA double-strand breaks: signaling, repair and the cancer connection

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Celecoxib enhances radiation response of secondary bone tumors of a human non-small cell lung cancer via antiangiogenesis in vivo.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Defective p53 signaling in p53 wild-type tumors attenuates p21waf1 induction and cyclin B repression rendering them sensitive to Chk1 inhibitors that abrogate DNA damage-induced S and G2 arrest

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Cell Cycle-Dependent Expression of Phosphorylated Histone H2AX: Reduced Expression in Unirradiated but not X-Irradiated G1-Phase Cells

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Vorinostat, a histone deacetylase inhibitor, enhances the response of human tumor cells to ionizing radiation through prolongation of gamma-H2AX foci

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Enhanced radiosensitivity of androgen-resistant prostate cancer: AZD1152-mediated Aurora kinase B inhibition.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Additive effects of 5-aza-2'-deoxycytidine and irradiation on clonogenic survival of human medulloblastoma cell lines

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Role of cell cycle in mediating sensitivity to radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Overexpression of the DNA-binding domain of poly(ADP-ribose) polymerase inhibits rejoining of ionizing radiation-induced DNA double-strand breaks

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Significant increase in residual DNA damage as a possible mechanism of radiosensitization by gemcitabine.

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Second malignancies in high‑dose areas of previous tumor radiotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Comparison of the micronucleus and chromosome aberration techniques for the documentation of cytogenetic damage in radiochemotherapy-treated patients with rectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Novel HDAC inhibitors with radiosensitizing properties

1 reference

https://api.crossref.org/works/10.1007%2FS00066-011-0028-5

21 January 2018

Histone deacetylase inhibitors in cancer therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/22249335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification of genes involved in repair of DNA double-strand breaks in mammalian cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22249335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiosensitization, after a combined treatment of survivin siRNA and irradiation, is correlated with the activation of caspases 3 and 7 in a wt-p53 sarcoma cell line, but not in a mt-p53 sarcoma cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/22249335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

HDAC inhibition radiosensitizes human normal tissue cells and reduces DNA Double-Strand Break repair capacity.

1 reference

https://pubmed.ncbi.nlm.nih.gov/22249335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Second malignant neoplasms after childhood cancer in Germany--results from the long-term follow-up of the German Childhood Cancer Registry

1 reference

https://pubmed.ncbi.nlm.nih.gov/22249335

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00066-011-0028-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22249335%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39411371&oldid=2213894090"